This inventor holds 1 USPTO granted patent. Top assignee: Taiho Pharmaceutical Company Limited. Active years: 2019.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019
Title: Naomoto Harada: Innovator in HLA Class I-Expressing Non-Human Animals
Introduction
Naomoto Harada is a prominent inventor based in Ibaraki, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of non-human animals that express HLA class I molecules. His innovative work has the potential to advance research in immunology and transplantation.
Latest Patents
Naomoto Harada holds a patent for an invention titled "HLA class I-expressing non-human animal." This invention provides a method for efficiently preparing a non-human animal that expresses HLA class I, allowing for the regulation of transgene copy number and integration site. The invention also details a method for preparing such animals, which can be crucial for various biomedical applications.
Career Highlights
Harada is associated with Taiho Pharmaceutical Company Limited, where he continues to contribute to groundbreaking research. His work focuses on enhancing the understanding of immune responses and developing novel therapeutic strategies.
Collaborations
Harada collaborates with Satoshi Fukaya, working together to push the boundaries of current scientific knowledge in their field.
Conclusion
Naomoto Harada's innovative contributions to biotechnology, particularly through his patent on HLA class I-expressing non-human animals, highlight his role as a key figure in advancing medical research. His work promises to have a lasting impact on the field of immunology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile